These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8314471)

  • 1. Recombinant alpha interferon for chronic hepatitis B in anti-HIV positive patients receiving zidovudine.
    Marcellin P; Boyer N; Colin JF; Martinot-Peignoux M; Lefort V; Matheron S; Erlinger S; Benhamou JP
    Gut; 1993; 34(2 Suppl):S106. PubMed ID: 8314471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zidovudine plus interferon alfa-2b treatment in patients with HIV and chronic active viral hepatitis.
    Visco G; Alba L; Grisetti S; Guarascio P; Narciso P; Sette P; Struglia C; Tossini G; Tozzi V
    Gut; 1993; 34(2 Suppl):S107-8. PubMed ID: 8314472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interferon-alpha and zidovudine combination therapy for chronic hepatitis B: results of a randomized, placebo-controlled trial.
    Janssen HL; Berk L; Heijtink RA; ten Kate FJ; Schalm SW
    Hepatology; 1993 Mar; 17(3):383-8. PubMed ID: 8444411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The interaction of human immunodeficiency virus infection and hepatitis B virus infection in infected homosexual men.
    Mai AL; Yim C; O'Rourke K; Heathcote EJ
    J Clin Gastroenterol; 1996 Jun; 22(4):299-304. PubMed ID: 8771427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alfa treatment of chronic hepatitis B: randomized trial in a predominantly homosexual male population.
    Wong DK; Yim C; Naylor CD; Chen E; Sherman M; Vas S; Wanless IR; Read S; Li H; Heathcote EJ
    Gastroenterology; 1995 Jan; 108(1):165-71. PubMed ID: 7806038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interferon alfa-2b therapy in children with chronic hepatitis B.
    Sokal EM; Wirth S; Goyens P; Depreterre A; Cornu C
    Gut; 1993; 34(2 Suppl):S87-90. PubMed ID: 8314496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-interferon for chronic active hepatitis B in human immunodeficiency virus-infected patients.
    Zylberberg H; Jiang J; Pialoux G; Driss F; Carnot F; Dubois F; Brechot C; Berthelot P; Pol S
    Gastroenterol Clin Biol; 1996; 20(11):968-71. PubMed ID: 9119186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled trial of recombinant alpha-interferon therapy for chronic hepatitis B.
    Di Bisceglie AM; Fong TL; Fried MW; Swain MG; Baker B; Korenman J; Bergasa NV; Waggoner JG; Park Y; Hoofnagle JH
    Am J Gastroenterol; 1993 Nov; 88(11):1887-92. PubMed ID: 8237937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomised controlled trial of interferon alfa 2A (rbe) (Roferon-A) for the treatment of chronic hepatitis B virus (HBV) infection: factors that influence response.
    Brook MG; McDonald JA; Karayiannis P; Caruso L; Forster G; Harris JR; Thomas HC
    Gut; 1989 Aug; 30(8):1116-22. PubMed ID: 2670693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interferon treatment of chronic active hepatitis B: effect of a six month treatment regimen.
    Raptopoulou M; Orphanou H; Vrettou H; Akribiadis E; Chadzikonstantinou L; Goulis G
    Gut; 1993; 34(2 Suppl):S102-3. PubMed ID: 8314469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon alpha treatment of chronic hepatitis C in HIV-infected patients receiving zidovudine: efficacy, tolerance and response related factors.
    Del Pozo MA; Arias JR; Pinilla J; Labarga P; Alcoba M; Martinez de la Cruz FJ; Anton F; Carro JA; Perez MR; Echevarria S; Garrote E; Moreno-Otero R
    Hepatogastroenterology; 1998; 45(23):1695-701. PubMed ID: 9840131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of quantitative assays for hepatitis B e antigen and IgM antibody to hepatitis B core antigen to monitor therapy in chronic hepatitis B.
    Hayashi PH; Beames MP; Kuhns MC; Hoofnagle JH; Di Bisceglie AM
    Am J Gastroenterol; 1996 Nov; 91(11):2323-8. PubMed ID: 8931411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of inapparent coinfection by hepatitis B virus in alpha interferon-treated patients with hepatitis C virus chronic hepatitis.
    Zignego AL; Fontana R; Puliti S; Barbagli S; Monti M; Careccia G; Giannelli F; Giannini C; Buzzelli G; Brunetto MR; Bonino F; Gentilini P
    J Med Virol; 1997 Apr; 51(4):313-8. PubMed ID: 9093946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicentre randomized clinical trial of recombinant alpha-2a interferon therapy in patients with chronic hepatitis B.
    Rumi M; Romeo R; De Filippi F; Marcelli R; Del Ninno E; van Eyken P; Desmet V; Colombo M
    Ital J Gastroenterol; 1993 Apr; 25(3):117-20. PubMed ID: 8507888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline hepatitis B surface antigen (HBsAg) as predictor of sustained HBsAg loss in chronic hepatitis B patients treated with pegylated interferon-α2a and adefovir.
    Takkenberg RB; Jansen L; de Niet A; Zaaijer HL; Weegink CJ; Terpstra V; Dijkgraaf MG; Molenkamp R; Jansen PL; Koot M; Rijckborst V; Janssen HL; Beld MG; Reesink HW
    Antivir Ther; 2013; 18(7):895-904. PubMed ID: 23639931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon alfa for chronic active hepatitis B. Long term follow-up of 62 patients: outcomes and predictors of response.
    Hope RL; Weltman M; Dingley J; Fiatarone J; Hope AH; Craig PI; Grierson JM; Bilous M; Williams SJ; Farrell GC
    Med J Aust; 1995 Jan; 162(1):8-11. PubMed ID: 7845310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term follow-up of HBeAg-positive patients treated with interferon alfa for chronic hepatitis B.
    Niederau C; Heintges T; Lange S; Goldmann G; Niederau CM; Mohr L; Häussinger D
    N Engl J Med; 1996 May; 334(22):1422-7. PubMed ID: 8618580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low dose interferon alfa-2b for chronic hepatitis B in Asian countries.
    Mauracher E
    Gut; 1993; 34(2 Suppl):S99-100. PubMed ID: 8314500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of sequential use of telbivudine in hepatitis B e antigen-positive chronic hepatitis B patients with partial responses to pegylated interferon: a pilot study.
    Huang Z; Zhao Z; Zheng Y; Peng L; Lin C; Deng H; Gao Z
    J Viral Hepat; 2013 Apr; 20 Suppl 1():52-7. PubMed ID: 23458525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.